Cargando…
Mesenchymal stem cells alleviate rat diabetic nephropathy by suppressing CD103(+) DCs‐mediated CD8(+) T cell responses
Diabetic nephropathy (DN) as a kind of serious microvascular complication of Diabetes Mellitus (DM) usually causes the end‐stage of renal disease (ESRD). Studies have demonstrated that CD103(+) dendritic cells (DCs) exhibited a renal pathogenic effect in murine chronic kidney disease (CKD). Mesenchy...
Autores principales: | Zhang, Fuping, Wang, Chengshi, Wen, Xin, Chen, Yang, Mao, Ruiwen, Cui, Danli, Li, Lan, Liu, Jingping, Chen, Younan, Cheng, Jingqiu, Lu, Yanrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214166/ https://www.ncbi.nlm.nih.gov/pubmed/32283569 http://dx.doi.org/10.1111/jcmm.15250 |
Ejemplares similares
-
Peritoneal M2 macrophage transplantation as a potential cell therapy for enhancing renal repair in acute kidney injury
por: Mao, Ruiwen, et al.
Publicado: (2020) -
Mesenchymal Stem Cells Attenuate Diabetic Lung Fibrosis via Adjusting Sirt3-Mediated Stress Responses in Rats
por: Chen, Yang, et al.
Publicado: (2020) -
The Closely Related CD103(+) Dendritic Cells (DCs) and Lymphoid-Resident CD8(+) DCs Differ in Their Inflammatory Functions
por: Jiao, Zhijun, et al.
Publicado: (2014) -
Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment
por: Li, Yuanmin, et al.
Publicado: (2018) -
The origin and development of nonlymphoid tissue CD103(+) DCs
por: Ginhoux, Florent, et al.
Publicado: (2009)